What Xerac AC Treats: Main Uses and Benefits

Xerac AC is used for the symptomatic management of Primary Focal Hyperhidrosis, a condition defined by the excessive and inappropriate production of sweat localized to areas such as the underarms, hands, or feet. The topical agent is commonly used in the initial therapeutic approach for this condition. It is considered relevant when standard non-prescription topical agents have failed to address the persistent and distressing manifestations of heightened physiological activity.

The solution helps address symptom clusters that may become intense or disruptive, such as excessive localized moisture, visible wetness, and functional distress. By achieving a reduction in chronic perspiration, the treatment provides supportive symptomatic relief that helps address the symptom clusters of skin maceration and irritation caused by continuous dampness. Managing these symptoms contributes to improved comfort during periods of heightened symptoms and may assist with maintaining functional stability, providing support that helps ease the overall symptom burden.

---

Quick Fact: Use in Symptom Management

Property	Description
Condition Category	Primary Focal Hyperhidrosis
Symptoms Managed	Localized moisture, Persistent wetness, Functional distress
Role	Supportive symptomatic relief
Benefit Focus	Helps improve day-to-day comfort

Regulatory References

1. NHS guidance on Hyperhidrosis

Who Can and Cannot Use Xerac AC

The eligibility for using Xerac AC (Aluminium Chloride Hexahydrate Topical Solution) is strictly defined by regulatory authorities to ensure safe application. This medicine is primarily indicated for adults seeking management of hyperhidrosis.

---

Contraindications and Prohibited Use

Classification	Restricted Population/Condition
Absolute Contraindication	Patients with a known hypersensitivity (allergy) to Aluminium Chloride Hexahydrate or any other component in the solution.
Prohibited Application	Use on broken, irritated, or recently shaved skin is strictly prohibited to prevent severe local reactions.

Conditional Use and Special Populations

Use is subject to caution and clinical consultation for specific populations due to the potential for increased systemic exposure or insufficient safety data:

• Pediatric Patients: Use in infants and children requires special care because their immature renal function may increase the risk of aluminum absorption.
• Renal Impairment: Patients with kidney disease or renal impairment should consult a clinician before use.
• Pregnancy and Lactation: The manufacturer recommends that the medicine not be used during pregnancy. While use during lactation is generally anticipated to be safe, all traces must be washed off the breast before nursing to prevent accidental infant ingestion.

The official interaction profile for Xerac AC is defined by two primary regulatory constraints: restrictions on local co-administration and potential interactions related to the product’s vehicle.

---

Interactions with Topical and Systemic Products

The most prominent constraint is a pharmacodynamic interaction involving concurrent external products. Regulatory documents state that other topical antiperspirants and deodorants must not be applied at the same treatment site as Xerac AC. This is classified as a local co-administration restriction.

Due to the formulation, the product’s Anhydrous Ethanol vehicle may introduce the potential for interaction with certain oral systemic medications. Official summaries include drugs known to be alcohol-sensitive, such as Disulfiram, Metronidazole, and Tinidazole, as substances that may interact through this route.

Complex systemic interactions, such as those related to CYP enzyme or transporter function, are not documented for the active ingredient, consistent with its minimal systemic absorption. Accordingly, no formal systemic drug-drug contraindications are established in the regulatory labeling.

Population-Specific Note: A specific regulatory caution is advised regarding use in patients with renal impairment. This note is based on the elimination route of any absorbed aluminum by the kidneys, which could potentially lead to increased exposure in this population.

How Xerac AC Works

The action of the active ingredient, Aluminium Chloride Hexahydrate, is fundamentally a physical and mechanical process.

Molecular Coagulation and Duct Blockade

The mechanism begins at the molecular level where the Aluminium Cation ( Al^3+) engages in a chemical coagulation reaction with the proteins and keratin lining the eccrine sweat duct. This interaction precipitates and aggregates the organic material, physically forming a robust, insoluble keratinous plug in the duct's distal opening. This process results in a physical occlusion, which is the primary mechanistic cascade of the compound.

Localized Anhidrosis and Reversible Action

The physical occlusion causes an interruption in the sweat excretion pathway, leading to a direct physiological consequence: localized anhidrosis (inhibition of sweating). This also generates hydrostatic back-pressure within the gland, which acts as a localized feedback signal to temporarily reduce the rate of fluid production. However, the blockade is temporary; the plug is naturally shed with the skin's surface cells (desquamation), making the mechanism inherently reversible.

How to Use Xerac AC

This section describes the high-level principles for the administration of Xerac AC (Aluminium Chloride Hexahydrate Topical Solution), focusing strictly on proper usage patterns.

---

Administration Overview

Feature	Official Usage Principle
Route of Administration	Application is strictly topical for external use on the skin.
Dosage Form and Strength	Used as a Topical Solution containing 6.25% Aluminium Chloride Hexahydrate.
Application Amount	The solution is applied sparingly to the affected area in a thin layer

---

Standard Use Regimen

The administration of the solution is structured into two distinct phases: an initial induction period and a long-term maintenance pattern.

Phase	Frequency and Duration
Initial Phase	Applied once daily at bedtime for a short course, generally two to three days, until control is achieved.
Maintenance Phase	Usage is reduced to an intermittent schedule, typically once or twice a week, as needed to maintain control of perspiration.

---

Procedural Conditions and Timing

Proper use is highly dependent on timing and the condition of the application site. The solution must be applied to an absolutely dry skin surface. The application takes place at bedtime to utilize the overnight period, with the solution designed to remain on the skin for a contact duration of six to eight hours. The treated area is required to be washed thoroughly with soap and water the following morning to remove the product. Due to the product’s flammability, it must be kept away from heat, sparks, and open flame.

Research Evidence / Overview of Studies for Xerac AC

Evidence for Use in Primary Axillary Hyperhidrosis (Underarm Sweating)

The active ingredient in Xerac AC, aluminum chloride hexahydrate, was studied for its application in research exploring excessive underarm sweating, a condition characterized by fluctuating or episodic manifestations known as primary axillary hyperhidrosis. Research in this area primarily includes Randomized Controlled Trials (RCTs), where the solution was evaluated in adult patient populations, sometimes comparing different concentrations or vehicles.

The main outcomes measured in these studies included quantitative sweat collection and patient-reported outcomes describing perceived discomfort. Studies report how symptoms evolved in the observed populations, with findings describing patterns observed related to short-term changes in moisture levels. This evidence contributes to the broader evidence landscape for this topical agent in this body area.

Evidence for Use in Palmar and Plantar Hyperhidrosis (Hand and Foot Sweating)

Research was also conducted for excessive sweating of the hands and feet. Studies included RCTs and non-controlled clinical trials, often comparing the topical solution against a placebo or other treatment modalities. Research was studied for outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level, focusing on conditions marked by functional limitations. The data show patterns related to symptom changes over short-term evaluation periods, and research suggests that studies exploring these sites may involve higher concentrations or comparisons with alternative methods.

Key Limitations and Areas of Research Uncertainty

Follow-up durations were limited in many studies, meaning long-term effects are not fully established regarding the persistence of measured sweat changes over many years. Furthermore, data for certain groups remain insufficient, particularly for patients with coexisting medical conditions or those outside the main adult cohort. Research also describes that the concentration of the active ingredient used may influence the findings, which contributes to some heterogeneity across the body of evidence. These limitations highlight that while research has explored how symptoms change, certainty remains low in some specific areas.

Key Studies & References

1. MedlinePlus: Hyperhidrosis

Common questions about Xerac AC (FAQ)

Q: Do you need a prescription or is Xerac AC sold over the counter?

According to the official regulatory classification, the formulation of Xerac AC containing 6.25% aluminum chloride hexahydrate is designated as an Over-The-Counter (OTC) Monograph Drug by the FDA. This classification means it is officially recognized as a non-prescription product.

Q: Is Xerac AC appropriate for people with very sensitive skin?

Official safety warnings state that Xerac AC should not be applied to skin that is broken, irritated, or recently shaved. Official product information states that use is typically stopped if irritation or sensitization occurs. Official documents emphasize the importance of following application instructions, particularly for individuals with sensitive skin.

Q: How quickly can most people expect to see results from using Xerac AC?

The official instructions for Xerac AC define an initial application phase that is typically applied nightly for two to three days. The regimen is typically maintained until the desired reduction in excessive sweating is described as achieved.

Q: Is it true that Xerac AC can cause flaking or peeling of the skin?

Regulatory sources list common side effects that occur at the application site, including localized irritation, redness, and dryness. While flaking or general peeling is not listed as a common effect, more severe symptoms, such as blistering or peeling skin, are cited in official warnings as signs of a possible serious allergic reaction that typically require attention from a healthcare professional.

Q: Can Xerac AC be safely used by teenagers?

The official dosing and usage schedules for the management of hyperhidrosis (excessive sweating) are described in official documents for both adults and adolescents.

Q: Is the medication Xerac AC the same thing as the raw ingredient aluminum chloride?

No, the medication is not the same as the raw ingredient alone. Official product information states that Xerac AC contains the active ingredient, aluminum chloride hexahydrate, which is dissolved in a base, known as a vehicle, that is listed as Anhydrous Ethanol (alcohol).

Q: Why does the product information emphasize that Xerac AC should be used on completely dry skin?

The label emphasizes this procedural condition because any moisture on the skin can react with the active ingredient and lead to the formation of an irritating weak hydrochloric acid. This procedural condition is important to prevent irritation.

Q: If I accidentally skip a day of using Xerac AC, do I need to apply extra the next time?

Regulatory administration instructions do not advise or provide any specific direction for applying a double or extra amount to compensate for a missed application.

Q: If I stop using Xerac AC, how long before my skin condition might return to its previous state?

The mechanism by which the drug controls perspiration is temporary and fully reversible. Clinical observations associated with the drug’s mechanism suggest that the original level of sweating may begin to return within approximately 48 hours after use is stopped.

Q: Is there a minimum age officially stated for using Xerac AC?

Official regulatory information states that the safety and effectiveness of Xerac AC have not been established for infants and young children. The product is listed for use in adults and adolescents.

Q: Is Xerac AC widely studied for use across all skin types and tones?

Clinical literature notes that in some studies, changes to skin tone, specifically the risk of post-inflammatory hyperpigmentation (PIH), have been observed as a greater concern for individuals with skin of color. This suggests that the safety profile may require consideration across various skin tones.

Q: Are the studies on Xerac AC's effectiveness based on human trials?

Yes. The body of evidence supporting the regulatory recognition and use of this solution includes Randomized Controlled Trials (RCTs), which are the standard for human clinical studies.

Q: Why is Xerac AC only applied once a day?

The official regimen instructs application at bedtime because the body naturally sweats less during sleep. This timing is intentional as it maximizes the necessary overnight contact time for the active ingredient to effectively form the temporary plugs in the sweat ducts.

How to Store and Dispose of Xerac AC?

The official labeling for Xerac AC topical solution specifies strict conditions for storage and handling, primarily due to the product's flammable nature.

Storage Requirements

The medicine must be stored at controlled room temperature, specifically between 59°F and 86°F (15°C and 30°C). Since the solution contains alcohol and is flammable, it must be kept away from heat and away from an open flame. To maintain the concentration and stability, the container must be kept tightly closed as the medicine will evaporate quickly when exposed to air. For safety, it must be stored out of the reach of children and pets.

Disposal Instructions

When the product is expired or no longer needed, it must be properly discarded. Regulatory guidelines state that the solution must not be poured down the toilet or into a drain. For safe disposal, users must consult a pharmacist or local waste disposal company for procedures that comply with local regulations.